GGrantIndex
Sort

23,748 grants matching melanoma

A Pilot Study of a Spiritually-Focused Intervention

$192,618
University Of Pittsburgh At Pittsburgh · R21 · FY2005 · CA

SPONTANEOUS MELANOMA DEVELOPMENT IN TRANSGENIC MICE

$192,599
Rutgers The St Univ Of Nj New Brunswick · R01 · FY2001 · CA

Modeling and Targeting Adaptive Signaling Responses in Single NRAS Mutant Melanoma Cells

$192,530
Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2015 · CA

Interleukin-33 in skin carcinogenesis

$192,500
Traci A Wilgus · Ohio State University · R21 · FY2015 · ES

Identification of a novel tumor suppressorof melanoma and UV-induced genome instability

$192,500
Weihang Chai · Loyola University Chicago · R21 · FY2022 · ES

Differential miRNA expression & progression of arsenic induced skin cancers

$192,500
J Christopher States · University Of Louisville · R21 · FY2016 · ES

Role of PRMT5 in HTLV-1 transformation and disease

$192,500
Patrick Lee Green · Ohio State University · R21 · FY2015 · AI

Exploring miR-29 in melanoma progression and prevention

$192,493
Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA

TCR Engineering of Quiescent Primary Human T Cells

$192,488
Michael I Nishimura · Medical University Of South Carolina · R21 · FY2010 · CA

Predictive biomarker development in lung cancer: ROS1 chromosomal rearrangements

$192,488
Anthony John Iafrate · Massachusetts General Hospital · R21 · FY2012 · CA

Defining oncogenic capacities of PAK7 mutations in human cancer

$192,488
Steen Henning Hansen · Boston Children'S Hospital · R21 · FY2016 · CA

Clinical Research

$192,457
Richard M Goldberg · Univ Of North Carolina Chapel Hill · P30 · FY2012 · CA

CONTROLLING NK CELL ANTI-CANCER ACTIVITY: THE ROLE OF NUTRIENTS AND SUPPLEMENTS

$192,409
Marco Colonna · Washington University · R21 · FY2014 · CA

Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy

$192,346
Robert S Kerbel · Sunnybrook & Women'S Coll Hlth Scis Ctr · R01 · FY2012 · CA

Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy

$192,346
Robert S Kerbel · Sunnybrook & Women'S Coll Hlth Scis Ctr · R01 · FY2011 · CA

Neuroimmunology of Vaccines in Adoptive T-cell Therapy for Brain Tumor

$192,325
John H Sampson · Duke University · R21 · FY2011 · NS

Southwest Oncology Group

$192,303
George Thomas Budd · Cleveland Clinic Lerner Com-Cwru · U10 · FY2006 · CA

Systematic Profiling of Nonhomologous End Joining in Cancer

$192,262
Dale A Ramsden · Univ Of North Carolina Chapel Hill · R21 · FY2014 · CA

Enhancing the efficacy of immunotherapy by optimal use of SMAC mimetics

$192,240
Shengqing Gu · University Of Tx Md Anderson Can Ctr · K22 · FY2024 · CA

Enhancing the efficacy of immunotherapy by optimal use of SMAC mimetics

$192,240
Shengqing Gu · University Of Tx Md Anderson Can Ctr · K22 · FY2025 · CA

University of Utah Biomedical Informatics Training

$192,228
Joyce A Mitchell · University Of Utah · T15 · FY2008 · LM

Photoacoustic detection of circulating melanoma cells in blood

$192,214
John A Viator · University Of Missouri-Columbia · R21 · FY2010 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$192,043
University Of Pretoria · U10 · FY2001 · CA

Core C: Administrative Core

$192,032
Joseph G Ibrahim · Univ Of North Carolina Chapel Hill · P01 · FY2007 · ES

Molecular Modifiers of Endometrial Endometrioid Adenocarcinoma Immune Microenvironment: Impact of PTEN loss and CD73-Generated Adenosine Loss

$192,000
Russell R Broaddus · University Of Tx Md Anderson Can Ctr · P50 · FY2017 · CA